Your results have been filtered for all content within all Money Map Press subscriptions

When we entered our position in Otonomy Inc. (NasdaqGS:OTIC) on Monday, I indicated we would be doing so in three stages, each time investing a third of our capital.

Our entry price was $23.38. In the past couple of days, shares have fallen about 9%, creating a great buying opportunity for us, which will average down our cost.

So today, the time has come to purchase the second of three portions in this position.

Talk with you soon. I have another great stock I'd like to recommend.

 
Your current subscriptions do not allow access to this search result.
Learn More

There's one aspect of today's choppy market that's getting almost zero attention from the mainstream media - technical analysis.

As a veteran tech trader who spends hours a week looking at charts, I can tell you firsthand that finding stocks with good technical signals has become extraordinarily difficult.

Most charts show stocks on wild roller-coaster rides...

That's why I'm so excited about BioTelemetry Inc. (Nasdaq: BEAT) - not only does it offer us strong fundamentals, but it has one of the best charts I've seen in weeks.

The way I determine that is by using my Real Demand Tracking System (RDTS) system. This unique charting approach reveals the "true demand" for any stock I want to trade.

 
Your current subscriptions do not allow access to this search result.
Learn More

On Sunday, we heard insight from William Strauss, the chief advisor to Chicago Federal Reserve Bank President Charles Evans. During a speech last week, Strauss offered five key insights for the U.S. markets, and said that an interest rate hike is far less likely in September than many have reported.

That said, there was a key takeaway during the end of his presentation that no one is really talking about today. Strauss indicated that Brazil, Russia, and China's economies are keeping central bankers around the world up at night.

But the final emerging market from the "BRIC" designation - India - has "nowhere to go but up," according to Strauss. Steep economic reforms and a stronger central bank are putting the nation on a path toward growth. The country's new prime minister is reducing bureaucracy and cutting red tape in an effort to spur business development.

 
Your current subscriptions do not allow access to this search result.
Learn More

The markets broke down Monday as I suspected they might, although yesterday's trading action was a drop in the bucket compared to last week's 1089-point ripper. Monday's close means the S&P 500 has shed 6.26% in what is now the worst single month since 2012. Dow Jones data show that this is the worst August in 20 years.

At the same time, the S&P 500 and the Dow, in particular, also had a historic five days of gains or losses of more than 2%, which makes August the most volatile month in almost four years, according to Yahoo!Finance.

 
Your current subscriptions do not allow access to this search result.
Learn More

As I told you yesterday, Money Calendar continues to show bullish sentiment, flashing all green for this week. Once again, that means it has no bearish candidates that show a 100% gain opportunity.

But it does have an excellent bullish opportunity lined up. We've got a lot of ground to cover today - including a look at our open positions and some housekeeping to tend to on our SPY trade - so let's get right to it.

 
Your current subscriptions do not allow access to this search result.
Learn More

Money Calendar is signaling bullish sentiment all week, and it seems to be coinciding with what could be a relief rally following last week's incredible drop in the markets.

If that's the case, this week's bullish candidate from Money Calendar (I'll have more on that for you tomorrow) should have an even greater chance of working to the upside. 

As always, our goal will continue to be 100% returns on these trades. But there's one thing I want you to keep in mind as we head into the week.

 
Your current subscriptions do not allow access to this search result.
Learn More

I've been poking around some off-the-beaten track biotechs over the past couple of weeks, and guess what? It turns out there's a fortune to be made in helping little kids with earaches.

Not the kind of condition you'd think would spark a researcher's intense interest, but one small company, based in San Diego, CA, Otonomy Inc. (NasdaqGS:OTIC), has discovered a huge need in this market and its developed a product to meet that need.

When a child has an ear infection (otitis media or OM), fluid can build up behind the ear drum, in the area called the "middle ear," resulting in a lot of pain and sometimes fever.  The condition is called middle ear effusion, and it's the most common reason that children end up in their pediatrician's office. (Adults also get ear infections, but not nearly as often as kids do. Up to 75% of middle ear effusion patients are under the age of five.)

 
Your current subscriptions do not allow access to this search result.
Learn More

The fast-paced global drone industry is no slacker. Despite hitting roadblocks while all of the government policy details are hammered out, this multibillion dollar industry is hardly sitting on the sidelines.

In fact, in July of this year, the first legal commercial delivery by drone in the country completed by a consortium led by Virginia Tech.

The drone carried out a 22-mile flight through the mountainous area in the southwestern part of Virginia to deliver a shipment of medicine to a medical facility in a rural area.

U.S. Senator Mark R. Warner (D-VA) called it "a real 'Kitty Hawk' moment for the unmanned systems industry" eluding to the area where manned U.S. aviation was born in 1903.

 
Your current subscriptions do not allow access to this search result.
Learn More